ly developed calcium antagonist drug, showed a significant tissue selectivity for intestine smooth muscle in preliminary experiments Wallis et al., 1994) . potently inhibited small and large bowel motility stimulated by cholesytokinin octapeptide, with cardiovascular effects being evident only at doses 10 times higher. This contrasted with calcium channel blockers such as nifedipine and diltiazem which produced dose-related cardiovascular effects over the same dose-range as those required to inhibit motility ). UK-84149 was able to inhibit calcium-induced contracture of depolarized guinea-pig ileum which could be reversed by the addition of excess calcium, indicating that a calcium antagonist effect might be involved in the effects of UK-84149 . The purpose of the present -experiments was to investigate the action of UK-84149 on calcium currents from the guinea-pig jejunum, rabbit jejunum, and coronary artery smooth muscle cells, and to compare it with verapamil, nicardipine and ' Author for correspondence. D600 by using the whole-cell voltage clamp recording technique.
Methods
Single cell dispersion Rabbits were killed by overdose of pentobarbitone and guinea-pigs by cervical dislocation and exsanguination. Strips of the longitudinal smooth muscle layer of the guinea-pig or rabbit jejunum were cut into small pieces (3-4 mm) and incubated for 10 min in low Ca (10 tiM) physiological salt solution (PSS) and then transferred to a low-Ca medium containing 0.4 mg ml-l collagenase (Sigma, type XI) and 0.4 mg ml' protease (Sigma, type E) for 20 min at 37'C. At the end of digestion, the tissue was washed with low-Ca PSS without enzyme and agitated mildly by sucking in and out of a wide-bore pipette. The suspension of cells was then centrifuged and the pellet re-suspended in PSS containing about 0.4 mM Ca. Cells were maintained at 4°C and used within 6 h. All experiments were at room temperature (20-26'C) .
The left descending coronary artery of rabbit was identified under the binocular microscope and was isolated carefully.
The connective tissue was removed and the artery was cut into small pieces (2-3 mm). The procedure for dispersion BrRish Journal of Pharmacology (1995) 114. 1657-1665 was similar to that for jejunum except higher levels of enzymes (collagenase 0.6 mg ml -, protease 0.6 mg ml ) and longer incubation time (30 min) were used.
Electrical recordings
Cells were voltage-clamped by use of the whole-cell configuration of the patch-clamp technique (Hamill et al., 1981) or perforated patch recording technique in which nystatin (1I00 pg ml-') was added to the pipette solution (Horn & Marty, 1988) . The current-voltage converter was a patchclamp amplifier (Biologic). Analogue signals were recorded on FM-tape (Racal) at a tape speed of 3.75 in s'. Firepolished pipettes were prepared from borosilicate glass using a patch electrode puller (Narishige Sci. Inst. Lab.). The resistances of the pipettes were 2-4 MQ for jejunum smooth muscle cell recordings and 3-5 MC for rabbit coronary artery smooth muscle cell recordings. Cells were placed in the chamber (0.3 ml) on the stage of an inverted microscope, which was perfused continuously with solution at a rate of about 2 ml min-'. Command pulses were applied and signals were digitized at 2 kHz using a CED 1401 interface in conjunction with a 386 PC or a BBC microcomputer.
Solutions
The normal PSS (physiological salt solution) in the bath had the following ionic composition (mM): NaCl 130, KCl 5, MgCl2 1.2, CaCl2 1.7 or 2.5, glucose 10, HEPES 10, and was titrated to pH 7.4 with NaOH. The pipette solutions had the following ionic composition (mM): (1) Cs solution; CsCl 135, MgCl2 5, EGTA 5, HEPES 5. To make an ATP-generating solution ATP (3 mM), GTP (0.1 mM), creatine phosphate (15 mM), and creatine phosphokinase (50 u ml-') were added or nystatin (100 jig ml-') was added for perforated patch Time (min) Figure 1 Time course of changes in size of peak inward current in guinea-pig jejunum smooth muscle cell recorded using three types of Cs-containing pipette solution. (a) Conventional whole cell recording with ATP-free pipette solution; (b) conventional whole cell recording with 3 mM ATP, 15 mM creatine phosphate and 50 u mlP creatine phosphokinase in the peptide solution; (c) 'perforated patch' whole cell recording with 100 jig ml-nystatin in the pipette solution. The times after the cell membrane was ruptured are indicated. 
Results
Ca current rundown Figure 1 shows inward Ca current from rabbit jejunum smooth muscle cell evoked by stepping from a holding potential of -80 mV to 0 mV. With caesium chloride in the pipette, outward K current was apparently abolished because no difference was observed when 20 mM TEA was included in the pipette and bath solution (data not shown). In standard whole cell recording mode when no ATP was included in the pipette solution, the peak amplitude of the voltageactivated Ca current gradually decreased with time after a transient increase; the peak inward current decreased to 19 ± 14% (n = 5) of its initial value 20 min after rupture of the membrane patch. ATP (5 mM) markedly delayed the rundown of inward current (data not shown rundown was delayed further and the initial increase of the peak inward current persisted even as long as 20 min; thereafter the Ca current eventually declined to 58 ± 17% (n = 3) of its initial peak amplitude at 60 min. With I00 jg ml-' nystatin in the pipette solution ('perforated patch' recording mode), run down of inward current was usually negligible for 30 min or longer but by 60 min run down was apparent. Thus, run down was very slow compared with standard whole cell recordings. The peak inward current 50 min after gaining electrical access to cell (series resistance 10-30 Mfl) was still 96 ± 16% of its initial value (n = 3). Rundown of inward current is a problem when constructing concentration-response relationships for calcium antagonists, because the block often took a long time to reach steadystate. Thus, nystatin pipette solution was used for constructing concentration-response relationship for the effects of UK-84149, D600 and nicardipine on inward calcium current from rabbit jejunum and coronary artery cells and ATP-generating pipette solution was used for the rest of the experiments which involved observations on inward calcium current. Effects of UK-84149 on inward and outward current from guinea-pig jejunum smooth muscle cells Figure 3 shows the effects of UK-84149 on inward and outward currents from guinea-pig jejunum smooth muscle cells. In these experiments, high K solution was used in the pipette solution. When the cell was stepped more positive than -20mV from -80 mV, both inward and outward currents were observed (Figure 3(a)(i) and (ii) ). Figure 3(a)(i) and (a)(ii) shows the effect of UK-84148 on the currentvoltage relationship of inward and outward currents which were inhibited at all potentials (-20 to + 30 mV) after application for 10 min. Figure 3 (b)(i) and (ii) shows the relationship between the amplitude of inward and outward currents and concentrations of UK-84149. Inward and outward currents were evoked by stepping to + 10 mV for 300 ms from -80 mV, every 20 s. Figure 3(b)(i) shows the effect of UK-84149 on peak inward, peak and end of pulse outward current from one cell. It seems that UK-84149 was much slower to take effect on inward current than on outward currents, with a delayed start and a delayed steady-state (Figure 3(b)(i) ). Figure 3(b) (ii) shows the data from 4 cells. UK-84149 was a more potent inhibitor of the end of pulse outward current than the peak outward current and accelerated the decay of the outward current. The IDms for the effects of UK-84149 on peak inward, peak outward and end of pulse outward current were 2.3, 7.2 and 3.3 EM, respectively.
The effect of UK-84149 on the availability of the inward current
The availability of the inward current was tested by means of -20 0 20 a double pulse protocol. The peak inward current was evoked by a test potential of 0 mV after holding for 10 s at various conditioning potentials. The holding potential was -80 mV. Double pulses were applied at 20 s intervals. In the control, the inward current amplitude evoked by a test pulse was reduced when conditioning potentials were more positive than -60 mV. Figure 4a shows that the current was half available at Vh = -30 mV, and the slope, Vs, was 5.5, when evoked by the first pulse after stopping had recovered to about 80% of the control size. Figure 
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Verapamil 3 gM after washout of verapamil. Figure 5c shows the effect of nicardipine on inward current. In contrast to verapamil, nicardipine had little use-dependent action on the inward current. Upon resting in the presence of nicardipine (0.1 JiM)
for 3 min, the inward current 'evoked by the first pulse was 33% of current size before rest, which was almost the same value as that after 5 min stimulation. UK-84149, more like verapamil, showed similar use-dependent action on inward current (Figure 5d ). After resting in the presence of 3 ptM UK-84149 for 3 min, the amplitude of the inward current evoked by the first pulse did not change, compared with that before rest. Thereafter it decreased gradually and reached a steady state about 10min later. However unlike verapamil, Calcium channels blocked by UK-84149
wash out the effect of UK-84149 on inward current. The poor recovery of the inward current after stopping stimulation in the continuous presence of UK-84148 (31M) was probably due to the strong binding of UK-84148 to the receptor. To clarify the use-dependent effect of UK-84148, cells from guinea-pig jejunum were exposed to (3LM) for 10min before stimulating, and the block of the inward current was compared with that achieved with continuous repetitive simulation for 10min in the presence of UK-84148 (3 AIM). Figure 6 shows the results of these experiments. When cells were exposed to UK-84148 (3 1M) for 10min before stimulating, the inward current was only slightly inhibited, although the inward current gradually decreased after the stimulation was reapplied to the cell in the continuous presence of UK-84148 (Figure 6a ). However, when the cell was exposed to UK-84148 (3tM) for 10min and was repetitively simulated without any rest period the inward current was greatly inhibited (Figure 6b ). Figure 6c shows the summarized data. In 4 cells, the inhibition of the inward current by UK-84148 (3 1M) without stimulation was 5.3 ± 3.6% (from 486 ± 60 pA to 470 ± 51 pA) which was significantly (P <0.01) less than that with repetitive stimulation (52± 8%; from 455 ± 59pA to 219± 50pA, n=4).
Effects of UK-84149, D600 and nicardipine on inward currents from rabbit jejunum and coronary artery smooth muscle cell Figure 7 shows the effect of UK-84149 on inward current from rabbit jejunum and coronary artery smooth muscle cells, compared with the effects of D600 and nicardipine. The nystatin recording method was used in these experiments. The cell was held at -80 mV and stepped to 0 mV for 50 ms, every 20 s. A 10 ms 10 mV depolarizing pulse was used to monitor the series resistance. The drugs were bath applied and perfusion was continuous at a rate of 2 ml min'. Cadmium (100 1M) was used to abolish inward current completely at the end of the experiments and create a base line for measurement. Terada et al., 1987a) . Like the effect of verapamil and nicardipine on rabbit ileum smooth muscle cells (Terada et al., 1987a) , UK-84149 accelerated the outward current decay. In general, the selectivity of the Ca antagonists for the Ca inward current in smooth muscle cells was low in comparison with that seen in cardiac cells (Hume, 1985) . However, the ID50 values for the inhibition of outward current by different Ca antagonists in different tissues (smooth muscle, cardiac and neurone) were quite similar, ranging from 1-16 1AM (Nishi et al., 1983; Hume, 1985; Terada et al., 1987a ; Figure 3 ), but the IDM values for the inhibition of inward current by different Ca antagonists in different tissues were dramatically different, ranging from 16 nm to 9 1AM (Nishi et al., 1983; Hume, 1985; Terada et al., 1987b,c; Figure 6 ). Hence, inhibition of voltage-dependent outward currents by Ca antagonists seems to be due to a non-specific blocking action of higher concentrations.
UK-84149 shifted the voltage-dependent inactivation curve to the left. Nicardipine and other dihydropyridines have been shown to shift the voltage-dependent inactivation curve to the left when the conditioning pulses were 10 s (the same condition as used in the present experiment) (Terada et al., 1987bc) . Therefore, shifting the voltage-dependent inactivation curve to the left seems to be one of the common features of calcium channel blockers.
In most smooth muscles the Ca current can be dissected into components on the basis of its voltage-and timedependent properties (Aaronson et al., 1986; Caffrey et Nicardipine (gM) Figure 7 Effect of UK-84149, D600 and nicardipine on inward current of rabbit coronary artery and jejunum smooth muscle cells. (Terada et al., 1987b; present data) . In the present experiments, UK-84149 showed a use-dependent block which may explain, at least partially, why UK-84149 was more potent on the bowel than on blood vessel Wallis et al., 1994) , since bowel has a high rate of spontaneous activity and artery is quiescent under normal condi- 
